Market Tracker

09/04 6:08am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

228.47
Delayed Data
As of Sep 03
 -3.71 / -1.60%
Today’s Change
111.41
Today|||52-Week Range
263.81
+59.65%
Year-to-Date

Today’s Trading

Previous close232.18
Today’s open233.37
Day’s range226.57 - 235.36
Volume1,485,526
Average volume (3 months)1,774,625
Market cap$79.2B
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+38.91%
Earnings growth (next 5 years)+23.80%
Revenue growth (last year)+43.22%
P/E ratio94.7
Price/Sales5.93
Price/Book14.62

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.56+1.77%
LLYEli Lilly and Co-0.21-0.26%
ABTAbbott Laboratories-0.10-0.23%
CELGCelgene-1.93-1.61%
Data as of 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$2.71
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts